Overview
Disorder of glycolysis is a group of rare inherited metabolic conditions that affect how your body breaks down glucose (sugar) to produce energy. Glycolysis is one of the most important chemical pathways in the body — it is the process by which cells convert glucose into usable energy. When one of the enzymes involved in this pathway does not work properly due to a genetic change, cells cannot produce energy efficiently. This can affect many organs and tissues, especially those with high energy demands like red blood cells, muscles, and the brain. Symptoms vary depending on which specific enzyme is affected, but common problems include chronic anemia (low red blood cell counts), muscle weakness, exercise intolerance, and sometimes neurological issues. In some forms, red blood cells break down too quickly, a condition called hemolytic anemia. Other forms may primarily affect the muscles, causing cramps, pain, or weakness during physical activity. Treatment is mostly supportive, as there is currently no cure for most glycolysis disorders. Management may include blood transfusions for severe anemia, careful monitoring of energy levels, dietary adjustments, and avoidance of triggers that worsen symptoms. Some patients benefit from supplements or specific dietary strategies. Early diagnosis and ongoing care from a team of specialists can help improve quality of life. Well-known specific disorders within this group include pyruvate kinase deficiency, phosphofructokinase deficiency (Tarui disease), and glucose-6-phosphate isomerase deficiency, among others.
Key symptoms:
Chronic anemia (low red blood cell count)Yellowing of the skin and eyes (jaundice)Fatigue and low energyMuscle weaknessMuscle cramps or pain during exerciseExercise intoleranceEnlarged spleenDark-colored urineGallstones at a young ageShortness of breathPale skinDelayed growth in childrenNeurological problems in some formsRecurrent infections in some forms
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Variable
Can begin at different ages, from infancy through adulthood
FDA & Trial Timeline
4 eventsAgios Pharmaceuticals, Inc. — PHASE3
Agios Pharmaceuticals, Inc. — PHASE3
Massachusetts General Hospital
Agios Pharmaceuticals, Inc.
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Disorder of glycolysis.
4 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.
View clinical trials →Specialists
View all specialists →No specialists are currently listed for Disorder of glycolysis.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Disorder of glycolysis.
Community
No community posts yet. Be the first to share your experience with Disorder of glycolysis.
Start the conversation →Latest news about Disorder of glycolysis
No recent news articles for Disorder of glycolysis.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.Which specific enzyme or gene is affected in my case, and what does that mean for my symptoms?,Will I or my child need regular blood transfusions, and if so, how will iron overload be managed?,Is splenectomy recommended, and what are the risks and benefits?,Are there any new or emerging treatments, such as mitapivat or gene therapy, that might apply to my specific type?,What physical activities are safe, and which should be avoided?,Should other family members be tested for this condition?,What warning signs should prompt me to seek emergency care?
Common questions about Disorder of glycolysis
What is Disorder of glycolysis?
Disorder of glycolysis is a group of rare inherited metabolic conditions that affect how your body breaks down glucose (sugar) to produce energy. Glycolysis is one of the most important chemical pathways in the body — it is the process by which cells convert glucose into usable energy. When one of the enzymes involved in this pathway does not work properly due to a genetic change, cells cannot produce energy efficiently. This can affect many organs and tissues, especially those with high energy demands like red blood cells, muscles, and the brain. Symptoms vary depending on which specific enz
How is Disorder of glycolysis inherited?
Disorder of glycolysis follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
Are there clinical trials for Disorder of glycolysis?
Yes — 4 recruiting clinical trials are currently listed for Disorder of glycolysis on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.